AVEO Pharmaceuticals, Inc. (AVEO) Financial Statements (2024 and earlier)

Company Profile

Business Address 30 WINTER STREET
BOSTON, MA 02108
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:77,16279,03787,32994,018102,920121,414
Cash and cash equivalents70,168 70,54268,84074,735121,414
Short-term investments 6,9925,19216,78425,17656,370 
Other undisclosed cash, cash equivalents, and short-term investments 273,84532(28,185) 
Receivables15,27912,9439,8118,3034,2201,144
Inventory, net of allowances, customer advances and progress billings1,3201,6941,6561,252  
Inventory1,3201,6941,6561,252  
Other undisclosed current assets3,8274,0525,9404,4044,6003,504
Total current assets:97,58897,726104,736107,977111,740126,062
Noncurrent Assets
Operating lease, right-of-use asset81130178560676790
Property, plant and equipment242259276292310326
Other noncurrent assets200100151258258258
Total noncurrent assets:5234896051,1101,2441,374
TOTAL ASSETS:98,11198,215105,341109,087112,984127,436
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities15,84513,52413,09614,4099,9418,686
Employee-related liabilities4,2373,4694,963   
Accounts payable3,6053,0142,7124,9253,1623,963
Accrued liabilities8,0037,0415,4219,4846,7794,723
Deferred revenue   5781,0721,5651,974
Debt5,182     
Derivative instruments and hedges, liabilities      2,595
Other liabilities     790790
Other undisclosed current liabilities10,4706,7805,0576,8955,1795,728
Total current liabilities:31,49720,30418,73122,37617,47519,773
Noncurrent Liabilities
Long-term debt and lease obligation33,24738,18937,96033,04532,87432,698
Long-term debt, excluding current maturities33,24738,18937,96033,02632,72532,437
Liabilities, other than long-term debt2,7802,7802,7802,4322,4322,517
Deferred revenue      85
Other liabilities2,7802,7802,7802,4322,4322,432
Operating lease, liability    19149261
Total noncurrent liabilities:36,02740,96940,74035,47735,30635,215
Total liabilities:67,52461,27359,47157,85352,78154,988
Equity
Equity, attributable to parent30,58736,94245,87051,23460,20372,448
Common stock353434343434
Additional paid in capital723,619721,653720,386718,494717,093715,741
Accumulated other comprehensive income (loss) (2)1(3)(2)  
Accumulated deficit(693,065)(684,746)(674,547)(667,292)(656,924)(643,327)
Total equity:30,58736,94245,87051,23460,20372,448
TOTAL LIABILITIES AND EQUITY:98,11198,215105,341109,087112,984127,436

Income Statement (P&L) ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Revenues25,30420,92017,64615,1737,5561,920
Cost of revenue
(Cost of Goods and Services Sold)
(3,065)(2,434)    
Other undisclosed gross profit   (4,737)   
Gross profit:22,23918,48612,90915,1737,5561,920
Operating expenses(29,393)(27,497)(19,069)(24,388)(22,620)(21,035)
Operating loss:(7,154)(9,011)(6,160)(9,215)(15,064)(19,115)
Nonoperating income (expense)(1,165)(1,188)(1,095)(1,153)1,467(3,007)
Interest and debt expense     (1,128)(611)
Loss from continuing operations:(8,319)(10,199)(7,255)(10,368)(14,725)(22,733)
Loss before gain (loss) on sale of properties:(8,319)(10,199)(7,255)(10,368)(14,725)(22,733)
Other undisclosed net income      611
Net loss:(8,319)(10,199)(7,255)(10,368)(14,725)(22,122)
Other undisclosed net income attributable to parent     1,128 
Net loss available to common stockholders, diluted:(8,319)(10,199)(7,255)(10,368)(13,597)(22,122)

Comprehensive Income ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Net loss:(8,319)(10,199)(7,255)(10,368)(14,725)(22,122)
Comprehensive loss:(8,319)(10,199)(7,255)(10,368)(14,725)(22,122)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3)4(1)(2)1,128 
Comprehensive loss, net of tax, attributable to parent:(8,322)(10,195)(7,256)(10,370)(13,597)(22,122)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: